BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32749084)

  • 1. [A diagnostic-therapeutic pathway for patients with kidney stone disease: 2020 update].
    Cupisti A; Trinchieri A; Lombardi M; Agostini S; Arcidiacono T; Beltrami P; Berri E; Bevilacqua L; Campo S; Cannavò R; Croppi E; Casarrubea G; Caviglioli C; Crisci A; D'Addessi A; Sio M; Fantuzzi A; Fusaro M; Gambaro G; Garofalo M; Micali S; Marangella M; Petrarulo M; Piccinocchi G; Sessa A; Tasca A; Vezzoli G; Vitale C; Zattoni F;
    G Ital Nefrol; 2020 Aug; 37(Suppl 75):. PubMed ID: 32749084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Work-up of Patients with Urolithiasis: Indications and Diagnostic Algorithm.
    Tiselius HG; Daudon M; Thomas K; Seitz C
    Eur Urol Focus; 2017 Feb; 3(1):62-71. PubMed ID: 28720369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney and Ureteral Stones.
    Corbo J; Wang J
    Emerg Med Clin North Am; 2019 Nov; 37(4):637-648. PubMed ID: 31563199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal stones: evolving epidemiology and management.
    Schissel BL; Johnson BK
    Pediatr Emerg Care; 2011 Jul; 27(7):676-81. PubMed ID: 21730811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic evaluation of stone disease patients: a practical approach.
    Lifshitz DA; Shalhav AL; Lingeman JE; Evan AP
    J Endourol; 1999 Nov; 13(9):669-78. PubMed ID: 10608520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic Stone assessment: Underused tool and how to implement it on daily practice.].
    Castro Henríquez E
    Arch Esp Urol; 2021 Nov; 74(9):823-834. PubMed ID: 34726618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney Stones: Treatment and Prevention.
    Fontenelle LF; Sarti TD
    Am Fam Physician; 2019 Apr; 99(8):490-496. PubMed ID: 30990297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which Diet for Calcium Stone Patients: A Real-World Approach to Preventive Care.
    D'Alessandro C; Ferraro PM; Cianchi C; Barsotti M; Gambaro G; Cupisti A
    Nutrients; 2019 May; 11(5):. PubMed ID: 31137803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal shock wave lithotripsy versus ureteroscopy for management of pediatric nephrolithiasis in upper urinary tract stones: multi-institutional outcomes of efficacy and morbidity.
    Marchetti KA; Lee T; Raja N; Corona L; Kraft KH; Wan J; Ellison JS
    J Pediatr Urol; 2019 Oct; 15(5):516.e1-516.e8. PubMed ID: 31326329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and medical management of kidney stones in children.
    Tasian GE; Copelovitch L
    J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management.
    Sakhaee K; Maalouf NM; Sinnott B
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1847-60. PubMed ID: 22466339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.
    Dhondup T; Kittanamongkolchai W; Vaughan LE; Mehta RA; Chhina JK; Enders FT; Hickson LJ; Lieske JC; Rule AD
    Am J Kidney Dis; 2018 Dec; 72(6):790-797. PubMed ID: 30146423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the recurrent stone former.
    Chandhoke PS
    Urol Clin North Am; 2007 Aug; 34(3):315-22. PubMed ID: 17678982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for renal failure in nephrolithiasis.
    Gambaro G; Favaro S; D'Angelo A
    Am J Kidney Dis; 2001 Feb; 37(2):233-43. PubMed ID: 11157364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why is diagnosis, investigation, and improved management of kidney stone disease important? Non-pharmacological and pharmacological treatments for nephrolithiasis.
    D'Ambrosio V; Moochhala S; Unwin RJ; Ferraro PM
    Expert Rev Clin Pharmacol; 2022 Apr; 15(4):407-414. PubMed ID: 35612529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timely Evaluation and Management of Primary Hyperparathyroidism in Patients With Kidney Stones.
    Perez AA; Schneider DF; Long KL; Pitt SC; Sippel RS
    J Surg Res; 2018 Dec; 232():564-569. PubMed ID: 30463775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stone treatment in children: where we are today?
    Caione P; Matarazzo E; Battaglia S
    Arch Ital Urol Androl; 2010 Mar; 82(1):45-8. PubMed ID: 20593720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urine analyses for workup of kidney stone disease--interpretation and therapeutic consequences].
    Pasch A
    Ther Umsch; 2006 Sep; 63(9):569-74. PubMed ID: 17048170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.